# A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

> **NCT07414784** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **AbbVie** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** ABBV-295
- **DRUG:** Levonorgestrel/Ethinyl Estradiol

## Key facts

- **NCT ID:** NCT07414784
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-02-11
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07414784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07414784, "A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07414784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*